Kerstin Maria Kampa-Schittenhelm

Quizartinib (AC220) is a potent second generation class III tyrosine kinase inhibitor that displays a distinct inhibition profile against mutant-FLT3, -PDGFRA and -KIT isoforms

Kerstin Maria Kampa-Schittenhelm, Michael C. Heinrich, Figen Akmut et al. · Molecular Cancer · 2013 · 121 citations · Full text

The Kinase Inhibitors Sunitinib and Sorafenib Differentially Affect NK Cell Antitumor Reactivity In Vitro

Matthias Krusch, Julia Salih, Manuela Schlicke et al. · The Journal of Immunology · 2009 · 88 citations · Full text

Cancer Immunosurveillance, Medicine, Immunology +10

N terminus of ASPP2 binds to Ras and enhances Ras/Raf/MEK/ERK activation to promote oncogene-induced senescence

Zhiping Wang, Yuangang Liu, Maho Takahashi et al. · Proceedings of the National Academy of Sciences · 2012 · 56 citations · Full text

Apoptosis, Cell Death, Cancer Biology +20

Cell cycle-dependent activity of the novel dual PI3K-MTORC1/2 inhibitor NVP-BGT226 in acute leukemia

Kerstin Maria Kampa-Schittenhelm, Michael C. Heinrich, Figen Akmut et al. · Molecular Cancer · 2013 · 56 citations · Full text

Apoptosis-stimulating protein of p53 (ASPP2) heterozygous mice are tumor-prone and have attenuated cellular damage–response thresholds

Kerstin Maria Kampa-Schittenhelm, Jared D. Acoba, Dexi Chen et al. · Proceedings of the National Academy of Sciences · 2009 · 53 citations · Full text

Aspp2 Allele, Apoptosis, Immunology +20